These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22401486)

  • 1. Independent data and safety monitoring in psychiatric intervention research.
    Leon AC
    J Clin Psychiatry; 2012 Feb; 73(2):e257-63. PubMed ID: 22401486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data and safety monitoring policy for National Institute of Allergy and Infectious Diseases clinical trials.
    Dixon DO; Weiss S; Cahill K; Fox L; Love J; McNamara J; Soto-Torres LE
    Clin Trials; 2011 Dec; 8(6):727-35. PubMed ID: 22024105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences and challenges in data monitoring for clinical trials within an international tropical disease research network.
    Chen-Mok M; VanRaden MJ; Higgs ES; Dominik R
    Clin Trials; 2006; 3(5):469-77. PubMed ID: 17060220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the data safety and monitoring board in an international trial.
    NIMH Collaborative HIV/STD Prevention Trial
    AIDS; 2007 Apr; 21 Suppl 2():S99-102. PubMed ID: 17413269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring participant safety in phase I and II interventional trials: options and controversies.
    Hibberd PL; Weiner DL
    J Investig Med; 2004 Nov; 52(7):446-52. PubMed ID: 15651260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data and safety monitoring during randomized controlled trials of nursing interventions.
    Artinian NT; Froelicher ES; Vander Wal JS
    Nurs Res; 2004; 53(6):414-8. PubMed ID: 15586138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting of data monitoring boards in publications of randomized clinical trials is often deficient: ACTTION systematic review.
    Gewandter JS; Kitt RA; Hunsinger MR; Poku J; Lozano J; Chaudari J; Evans S; Gross RA; McDermott MP; Rowbotham MC; Turk DC; Dworkin RH
    J Clin Epidemiol; 2017 Mar; 83():101-107. PubMed ID: 28126598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sharing interim trial results by the Data Safety Monitoring Board with those responsible for the trial's conduct and progress: a narrative review.
    Borg Debono V; Mbuagbaw L; Thabane L
    Trials; 2017 Mar; 18(1):120. PubMed ID: 28279205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety methodology in pediatric psychopharmacology trials.
    Yuill K; Carandang C
    J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):148-62. PubMed ID: 23607408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DSMB. 1. What role, what responsibilities?].
    Brun-Buisson C
    Med Sci (Paris); 2005 Jan; 21(1):78-82. PubMed ID: 15639025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of data and safety monitoring in acute trauma resuscitation research.
    Champion HR; Fingerhut A; Escobar MA; Weiskopf RB
    J Am Coll Surg; 2007 Jan; 204(1):73-83. PubMed ID: 17189115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing training for Data Safety Monitoring Board members: A National Institute of Allergy and Infectious Diseases case study.
    Zuckerman J; van der Schalie B; Cahill K
    Clin Trials; 2015 Dec; 12(6):688-91. PubMed ID: 26152835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring factors associated with views on sharing of certain interim trial result measures by the data safety monitoring board (DSMB) with non-DSMB members.
    Borg Debono V; Mbuagbaw L; Paul J; Buckley N; Thabane L
    Trials; 2018 Nov; 19(1):621. PubMed ID: 30419939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behind closed doors: the data monitoring board in randomized clinical trials.
    Wittes J
    Stat Med; 1993 Mar; 12(5-6):419-24. PubMed ID: 8493420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data and safety monitoring board issues raised in the VA Status Epilepticus Study.
    Collins JF
    Control Clin Trials; 2003 Feb; 24(1):71-7. PubMed ID: 12559644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data and Safety Monitoring Board evaluation and management of a renal adverse event signal in TOPCAT.
    Bristow MR; Sharma K; Assmann SF; Linas S; Gersh BJ; Grady C; Rice MM; Singh S; Boineau R; McKinlay SM; Greenberg BH
    Eur J Heart Fail; 2017 Apr; 19(4):457-465. PubMed ID: 27873428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On being the statistician on a Data and Safety Monitoring Board.
    Whitehead J
    Stat Med; 1999 Dec; 18(24):3425-34. PubMed ID: 10611616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Securely sharing DSMB reports to speed decision making from multiple, concurrent, independent studies of similar treatments in COVID-19.
    Dilts NA; Harrell FE; Lindsell CJ; Nwosu S; Stewart TG; Shotwell MS; Pulley JM; Edwards TL; Serdoz ES; Benhoff K; Bernard GR
    J Clin Transl Sci; 2022; 6(1):e49. PubMed ID: 35656334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forming your phase III trial's data and safety monitoring board: a perspective on safety.
    Wittes J
    J Investig Med; 2004 Nov; 52(7):453-8. PubMed ID: 15651261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.